UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 262,572 Shares of Teladoc Health, Inc. (NYSE:TDOC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 38.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 423,868 shares of the health services provider's stock after selling 262,572 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.25% of Teladoc Health worth $3,853,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. raised its stake in shares of Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after acquiring an additional 384,528 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after purchasing an additional 22,664 shares during the last quarter. Commonwealth Equity Services LLC grew its holdings in shares of Teladoc Health by 35.7% during the 4th quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider's stock valued at $1,032,000 after purchasing an additional 29,903 shares during the last quarter. Xponance Inc. raised its position in Teladoc Health by 23.8% in the 4th quarter. Xponance Inc. now owns 13,861 shares of the health services provider's stock worth $126,000 after purchasing an additional 2,661 shares during the period. Finally, Vanguard Group Inc. lifted its stake in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after purchasing an additional 1,029,829 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Up 5.1%

Shares of NYSE TDOC traded up $0.35 during midday trading on Friday, hitting $7.28. 5,275,426 shares of the company traded hands, compared to its average volume of 6,288,824. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The firm has a market cap of $1.28 billion, a P/E ratio of -1.26 and a beta of 1.78. The stock has a 50-day moving average price of $7.15 and a 200 day moving average price of $9.12. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Insiders Place Their Bets

In related news, insider Adam C. Vandervoort sold 5,808 shares of the firm's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the sale, the insider now owns 69,773 shares of the company's stock, valued at $478,642.78. This trade represents a 7.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Carlos Nueno sold 3,958 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the transaction, the insider now owns 17,645 shares of the company's stock, valued at approximately $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,667 shares of company stock valued at $220,901. 0.58% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

TDOC has been the topic of a number of recent research reports. Bank of America reduced their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Canaccord Genuity Group decreased their price target on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Piper Sandler dropped their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. Finally, The Goldman Sachs Group cut their target price on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $9.60.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.